Bluejay Diagnostics, Inc.
BJDX
$1.95
$0.063.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 10.50% | 18.35% | -4.95% | -30.20% | 3.37% |
| Total Depreciation and Amortization | 54.43% | -17.71% | -26.01% | 38.40% | -30.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -83.97% | 3,445.45% | -184.62% | 1,400.00% | -101.75% |
| Change in Net Operating Assets | -147.08% | 225.84% | -121.50% | 1,204.76% | 92.25% |
| Cash from Operations | -6.99% | 33.80% | -73.36% | 18.36% | 32.64% |
| Capital Expenditure | -- | -- | -- | -- | -450.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -450.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 99.33% |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Financing | 371,220.00% | -100.03% | 338,200.00% | 23.08% | 99.12% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 253.04% | -202.55% | 211.91% | 18.43% | 36.87% |